Diag-Nose.io
PrivateLast Round
Grant
Aug 26, 2025
Total Funding Raised
$4.54M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Diag-Nose.io is a biotechnology company that provides an AI-powered precision medicine platform, RhinoMAP™, which uses proteomics and computational biology to analyze nasal samples for the diagnosis and treatment of chronic respiratory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Medical AI, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Diag-Nose.io Comparables
Compare Diag-Nose.io with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Noselab GmbH | 64% | |
| Owlstone Medical | 63% | |
| Illumina, Inc. | 60% |
Diag-Nose.io Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 26, 2025 | ||||
| Seed | Jan 29, 2025 | ||||
| Grant | Aug 19, 2024 |
Key People
Founding team and executive leadership
Diag-Nose.io Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LaunchVic | Grant |
| Monash University | Grant |
| The Actuator | Pre Seed |
| Artesian | Pre Seed |
| Radar Ventures | Seed |
| Specialty Physician Associates | Seed |
| Breakthrough Victoria | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 113% MoM, reaching 20K.
- Aug 26, 2025
$2M grant from Boosting Female Founders Initiative, Human Health, and Monash University.
Diag-Nose.io Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Diag-Nose.io's valuation, stock price, and market status.
Is Diag-Nose.io a public or private company?
Diag-Nose.io is a private company.
What is the current stock price of Diag-Nose.io?
Diag-Nose.io is a private company, so its shares have no public market price. Caplight tracks Diag-Nose.io's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Diag-Nose.io worth (valuation)?
Valuation information for Diag-Nose.io is not publicly available.
Can I buy Diag-Nose.io stock?
Diag-Nose.io shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Diag-Nose.io's last funding round?
Diag-Nose.io's most recent funding round was Grant on August 26, 2025.
Who are the main investors in Diag-Nose.io?
Key investors in Diag-Nose.io include Artesian, Breakthrough Victoria.
Will Diag-Nose.io IPO soon?
No public IPO plans have been announced for Diag-Nose.io.
How can I track Diag-Nose.io secondary market activity?
Caplight tracks bids, offers, and trades in Diag-Nose.io's shares on secondary markets.